Health costs analysis of hemophilia in Norway
Heger, H.; Hjort, P.F.; Evensen, S.A.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 100(14): 948-953
1980
ISSN/ISBN: 0029-2001 PMID: 7404544 Document Number: 162855
Document emailed within 1 workday
Related Documents
Rogoff, E.G.; Guirguis, H.S.; Lipton, R.A.; Seremetis, S.V.; DiMichele, D.M.; Agnew, G.M.; Karpatkin, M.; Barish, R.J.; Jones, R.L.; Bianco, C.; Knothe, B.D.; Lee, M-Soo. 2002: The upward spiral of drug costs: a time series analysis of drugs used in the treatment of hemophilia Thrombosis and Haemostasis 88(4): 545-553Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483
Lariviere, P.R. 1975: An analysis of the rise of health care costs in institutions in Canada and Quebec Dimensions in Health Service 52(8): 49-53
Rydlewska-Liszkowska, I.; Jugo, B. 2000: Analysis of costs involved in activities of regional occupational health centers Medycyna Pracy 51(4): 373-382
Kolacz, J.W. 1975: Methods of computing costs of prophylaxis and therapy of parasitic diseases in domestic animals: costs and cost analysis Wiadomosci Parazytologiczne 21(2): 329-338
Fogel, R.W.; Costa, D.L. 1997: A theory of technophysio evolution, with some implications for forecasting population, health care costs, and pension costs Demography 34(1): 49-66
Poon, M.C.; Hoar, D.I.; Low, S.; Pon, J.K.; Anand, S.; Sinclair, G.D. 1992: Hemophilia a carrier detection by restriction fragment length polymorphism analysis and discriminant analysis based on ELISA of factor VIIi and vWf Journal of Laboratory and Clinical Medicine 119(6): 751-762
Sebestyén, A.; Boncz, I.; Nyárády, József. 2006: Analysis of health insurance costs in cases of patients under 60 years old with medial femoral neck fracture treated primarily with screw fixation or hip replacement Orvosi Hetilap 147(24): 1129-1135
Rabøl, R.; Kolbye, A.; Andersen, S.Ejdrup. 2003: Drug costs in departments of internal medicine. An analysis of costs for patients and departments Ugeskrift for Laeger 165(15): 1565-1568
Eaton, J.W.; Menzies, N.A.; Stover, J.; Cambiano, V.; Chindelevitch, L.; Cori, A.; Hontelez, J.A.C.; Humair, S.; Kerr, C.C.; Klein, D.J.; Mishra, S.; Mitchell, K.M.; Nichols, B.E.; Vickerman, P.; Bakker, R.; Bärnighausen, T.; Bershteyn, A.; Bloom, D.E.; Boily, M-Claude.; Chang, S.T.; Cohen, T.; Dodd, P.J.; Fraser, C.; Gopalappa, C.; Lundgren, J.; Martin, N.K.; Mikkelsen, E.; Mountain, E.; Pham, Q.D.; Pickles, M.; Phillips, A.; Platt, L.; Pretorius, C.; Prudden, H.J.; Salomon, J.A.; van de Vijver, D.A.M.C.; de Vlas, S.J.; Wagner, B.G.; White, R.G.; Wilson, D.P 2014: Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models Lancet. Global health 2(1): e23-e34
Wright, S.; Henderson, C.; Thornicroft, G.; Sharac, J.; McCrone, P. 2015: Measuring the economic costs of discrimination experienced by people with mental health problems: development of the Costs of Discrimination Assessment (CODA) Social Psychiatry and Psychiatric Epidemiology 50(5): 787-795
Marum, M. 1997: General practice fundholding and health care costs. Fundholding has curbed increases in prescribing costs Bmj 315(7110): 748-749
Kapperud, G.; Lassen, J.; Aasen, S.; Hasseltvedt, V. 1994: Global transmission of Salmonella--increased risk in Norway. Interdisciplinary measures are necessary to maintain Norway's favourable situation Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(18): 2125-2129
Kim, K.; Aas, E. 2011: Cost-effectiveness analysis of olanzapine and risperidone in Norway Journal of Mental Health Policy and Economics 14(3): 125-135
Lillicrap, D.P.; Bridge, P.J.; Giles, A.R. 1990: Organization of a hemophilia genetic screening program. Ontario Hemophilia Study Group Progress in Clinical and Biological Research 324: 19-28
Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Vella, V.; Ng, T. 1986: Analysis of occupational mortality in England and Wales, Scotland, Norway and Finland La Medicina del Lavoro 77(2): 162-171
Nichols, S.; Mahoney, E.M.; Sirois, P.A.; Bordeaux, J.D.; Stehbens, J.A.; Loveland, K.A.; Amodei, N. 2000: HIV-associated changes in adaptive, emotional, and behavioral functioning in children and adolescents with hemophilia: results from the Hemophilia Growth and Development Study Journal of Pediatric Psychology 25(8): 545-556
Larsen, O.; Falkum, E. 1999: Health, medicine and population development in Norway Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 119(30): 4482-4487
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11